Tumor cell PD-L1 expression was not statistically significantly associated with DFS, whereas high tumor CD8+ T-cell density was predictive for longer DFS in the sunitinib arm of the S-TRAC trial [105]. The gene discussed is CD8A; the disease is neoplasm.